Related references
Note: Only part of the references are listed.Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
Elaine Rutherford et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients
Matthew P. M. Graham-Brown et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis
Sunil V. Badve et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Combination of Flow-Mediated Vasodilation and Nitroglycerine-Induced Vasodilation Is More Effective for Prediction of Cardiovascular Events
Masato Kajikawa et al.
HYPERTENSION (2016)
Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
Gang Deng et al.
MEDICAL SCIENCE MONITOR (2016)
Randomized Controlled Trial of Individualized Dialysate Cooling for Cardiac Protection in Hemodialysis Patients
Aghogho Odudu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Relationship between nitroglycerine-induced vasodilation and clinical severity of peripheral artery disease
Tatsuya Maruhashi et al.
ATHEROSCLEROSIS (2014)
Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling
Christopher T. Chan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy
Benjamin R. Szwejkowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Sushma Rekhraj et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline
Dick H. J. Thijssen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
Narasimharajapura S. Rajendra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease
Michelle P. Kao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
Michael V. Rocco et al.
KIDNEY INTERNATIONAL (2011)
What We Know About Oxidative Stress in Patients with Chronic Kidney Disease on Dialysis-Clinical Effects, Potential Treatment, and Prevention
Lucia Del Vecchio et al.
SEMINARS IN DIALYSIS (2011)
Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease A Randomized Controlled Trial
Nicola C. Edwards et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life - A randomized controlled trial
Bruce F. Culleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression
C Zoccali et al.
KIDNEY INTERNATIONAL (2004)
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States
AG Stack et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy
F Grothues et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies
W Doehner et al.
CIRCULATION (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force
MC Corretti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
R Butler et al.
HYPERTENSION (2000)
Share Paper
